title: Long-term effects of therapeutic vaccination with rgp 120.
authors.forename: K
authors.initials: K
authors.lastname: Lindenburg
authors.forename: M W
authors.initials: MW
authors.lastname: Langendam
authors.forename: J
authors.initials: J
authors.lastname: Veenstra
authors.forename: F
authors.initials: F
authors.lastname: Miedema
authors.forename: R
authors.initials: R
authors.lastname: Coutinho
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000628:therapy*; D018791:CD4 Lymphocyte Count; D005500:Follow-Up Studies; D015699:HIV Envelope Protein gp120 / Q000627:therapeutic use*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D013997:Time Factors; D014614:Vaccines, Synthetic / Q000627:therapeutic use; D014765:Viral Vaccines / Q000627:therapeutic use*
chemical_list: D015699:HIV Envelope Protein gp120; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D014765:Viral Vaccines